Physician profile
Christopher L Sneed
NPI 1568467454
$7,090.42
in general payments reported to CMS, 2019-2025
10 companies · $364 in 2025
The $364 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.00 · 2021: $1,205 · 2022: $20.55 · 2023: $1,416 · 2024: $4,036 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,087 · Food and Beverage: $729.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,086.92 |
| Food and Beverage | $729.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,345.53 | 2021-2024 | Everest Spinal System, N/A, Airo |
| Globus Medical, INC. | $2,462.29 | 2024-2025 | Excelsiusgps Robotic Navigation System, Excelsius Gps, Reline |
| Cerapedics INC. | $95.25 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Heron Therapeutics, INC. | $48.00 | 2019 | |
| Nuvasive, INC. | $37.01 | 2021 | |
| Djo, LLC | $32.28 | 2023 | Donjoy |
| Innovation Technologies INC | $24.16 | 2025 | Irrisept |
| Sanofi-Aventis U.S. LLC | $20.04 | 2023 | |
| Polynovo North America LLC | $13.79 | 2025 | Novosorb Btm |
| Medtronic, INC. | $12.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Sneed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.